Literature DB >> 35511090

Self-matched learning to construct treatment decision rules from electronic health records.

Tianchen Xu1, Yuan Chen2, Donglin Zeng3, Yuanjia Wang1,4.   

Abstract

Electronic health records (EHRs) collected from large-scale health systems provide rich subject-specific information on a broad patient population at a lower cost compared to randomized controlled trials. Thus, EHRs may serve as a complementary resource to provide real-world data to construct individualized treatment rules (ITRs) and achieve precision medicine. However, in the absence of randomization, inferring treatment rules from EHR data may suffer from unmeasured confounding. In this article, we propose a self-matched learning method inspired by the self-controlled case series (SCCS) design to mitigate this challenge. We alleviate unmeasured time-invariant confounding between patients by matching different periods of treatments within the same patient (self-controlled matching) to infer the optimal ITRs. The proposed method constructs a within-subject matched value function for optimizing ITRs and bears similarity to the SCCS design. We examine assumptions that ensure Fisher consistency, and show that our method requires weaker assumptions on unmeasured confounding than alternative methods. Through extensive simulation studies, we demonstrate that self-matched learning has comparable performance to other existing methods when there are no unmeasured confounders, but performs markedly better when unobserved time-invariant confounders are present, which is often the case for EHRs. Sensitivity analyses show that the proposed method is robust under different scenarios. Finally, we apply self-matched learning to estimate the optimal ITRs from type 2 diabetes patient EHRs, which shows our estimated decision rules lead to greater advantages in reducing patients' diabetes-related complications.
© 2022 John Wiley & Sons, Ltd.

Entities:  

Keywords:  individualized treatment rule; machine learning; precision medicine; self-controlled case series

Mesh:

Year:  2022        PMID: 35511090      PMCID: PMC9283315          DOI: 10.1002/sim.9426

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.497


  26 in total

1.  Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.

Authors:  Suetonia C Palmer; Dimitris Mavridis; Antonio Nicolucci; David W Johnson; Marcello Tonelli; Jonathan C Craig; Jasjot Maggo; Vanessa Gray; Giorgia De Berardis; Marinella Ruospo; Patrizia Natale; Valeria Saglimbene; Sunil V Badve; Yeoungjee Cho; Annie-Claire Nadeau-Fredette; Michael Burke; Labib Faruque; Anita Lloyd; Nasreen Ahmad; Yuanchen Liu; Sophanny Tiv; Natasha Wiebe; Giovanni F M Strippoli
Journal:  JAMA       Date:  2016-07-19       Impact factor: 56.272

Review 2.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

3.  Multiple self-controlled case series for large-scale longitudinal observational databases.

Authors:  Shawn E Simpson; David Madigan; Ivan Zorych; Martijn J Schuemie; Patrick B Ryan; Marc A Suchard
Journal:  Biometrics       Date:  2013-10-11       Impact factor: 2.571

4.  Global guideline for type 2 diabetes.

Authors: 
Journal:  Diabetes Res Clin Pract       Date:  2014-02-05       Impact factor: 5.602

Review 5.  Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology.

Authors:  R E Kibbelaar; B E Oortgiesen; A M van der Wal-Oost; K Boslooper; J W Coebergh; N J G M Veeger; P Joosten; H Storm; E N van Roon; M Hoogendoorn
Journal:  Eur J Cancer       Date:  2017-10-06       Impact factor: 9.162

6.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

7.  Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort.

Authors:  Chiung-Zuei Chen; Chih-Hui Hsu; Chung-Yi Li; Tzuen-Ren Hsiue
Journal:  J Asthma       Date:  2017-01-31       Impact factor: 2.515

8.  The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Authors:  Jennifer L Lund; David B Richardson; Til Stürmer
Journal:  Curr Epidemiol Rep       Date:  2015-09-30

9.  Statistical issues and limitations in personalized medicine research with clinical trials.

Authors:  Daniel B Rubin; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-07-20       Impact factor: 0.968

10.  Standards of Medical Care in Diabetes-2020 Abridged for Primary Care Providers.

Authors: 
Journal:  Clin Diabetes       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.